These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38556202)

  • 1. Application of the Simplified Psoriasis Index in the Routine Clinical Practice: A Pilot Study.
    Vidal Ruiz A; Sánchez Leiro Á; Eirís Salvado N; Carrizosa Esquivel AM; Moreno Ramírez D
    Actas Dermosifiliogr; 2024 Mar; ():. PubMed ID: 38556202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Simplified Psoriasis Index in Dutch children and adolescents with plaque psoriasis.
    van Geel MJ; Otero ME; de Jong EM; van de Kerkhof PC; Seyger MM
    Br J Dermatol; 2017 Mar; 176(3):771-776. PubMed ID: 27718521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the validity and response distribution of the simplified psoriasis index in patients receiving phototherapy.
    Meah N; Alsharqi A; Azurdia RM; Owens LC; Parslew R; Chularojanamontri L
    Australas J Dermatol; 2018 Feb; 59(1):41-47. PubMed ID: 27730628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the validity and interpretability of the Simplified Psoriasis Index in Tunisian patients.
    Chabchoub I; Litaiem N; Gara S; Jaber K; Dhaoui MA; Zeglaoui F
    Tunis Med; 2022 Janvier; 100(1):49-55. PubMed ID: 35822332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate-to-severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI-PSO study.
    Richard MA; Lacour JP; Konstantinou MP; Ruer-Mulard M; Joly P; Aractingi S; Auquier P; Pelvet B; Augustin ML; Mahé E; Chalmers RJG
    J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):677-684. PubMed ID: 32815591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Simplified Psoriasis Index (SPI): a practical tool for assessing psoriasis.
    Chularojanamontri L; Griffiths CE; Chalmers RJ
    J Invest Dermatol; 2013 Aug; 133(8):1956-62. PubMed ID: 23807685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness to change and interpretability of the simplified psoriasis index.
    Chularojanamontri L; Griffiths CEM; Chalmers RJG
    J Invest Dermatol; 2014 Feb; 134(2):351-358. PubMed ID: 23897275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of serum level of squamous cell carcinoma antigen with severity of cutaneous psoriasis, assessed using the simplified psoriasis index.
    Henry D; Alkhars A; Samimi M; Dufour D; Machet L
    Ann Dermatol Venereol; 2024 Mar; 151(1):103246. PubMed ID: 38422600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [French adaptation of a new score for global assessment of psoriasis severity: The Simplified Psoriasis Index (SPI)].
    Richard MA; Aractingi S; Joly P; Mahé E; Auquier P; Le Guen S; Acquadro C; Boucher F; Chalmers RJG
    Ann Dermatol Venereol; 2019 Dec; 146(12):783-792. PubMed ID: 31623858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study.
    Imafuku S; Kanai Y; Murotani K; Nomura T; Ito K; Ohata C; Yamazaki F; Miyagi T; Takahashi H; Okubo Y; Saeki H; Honma M; Tada Y; Mabuchi T; Higashiyama M; Kobayashi S; Hashimoto Y; Seishima M; Kakuma T
    J Dermatol Sci; 2021 Mar; 101(3):185-193. PubMed ID: 33495058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translation into Spanish and field-testing of a new score for evaluating psoriasis severity: The Simplified Psoriasis Index (SPI).
    Barquero-Orias DE; Armellini E; Anderson AJ; Armellini A; Ortega-Loayza AG; Helbling I; Chalmers RJG
    Actas Dermosifiliogr; 2022 Apr; 113(4):363-369. PubMed ID: 35623726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-Term Correlation of the Psoriasis Area Severity Index, the Nail Psoriasis Area Severity Index, and the Dermatology Life Quality Index, before and after Treatment, in Patients with Skin and Nail Psoriasis.
    Prevezas C; Katoulis AC; Papadavid E; Panagakis P; Rigopoulos D
    Skin Appendage Disord; 2019 Nov; 5(6):344-349. PubMed ID: 31799260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life quality among psoriasis patients based on Dermatology Life Quality Index evaluation and its association with psoriasis severity in China: a cross-sectional study.
    Chen Y; Wei L; Song Y; Zhang R; Kuai L; Li B; Wang R
    Ann Med; 2023 Dec; 55(1):2231847. PubMed ID: 37417705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI).
    Hägg D; Sundström A; Eriksson M; Schmitt-Egenolf M
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):452-6. PubMed ID: 24911993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies.
    Mattei PL; Corey KC; Kimball AB
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):333-7. PubMed ID: 23425140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Reported Disease Severity and Quality of Life Among Arabic Psoriatic Patients: A Cross-Sectional Survey.
    Soliman M
    Clin Cosmet Investig Dermatol; 2020; 13():601-609. PubMed ID: 32943898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and psychologic measures are necessary to assess overall psoriasis severity.
    Kirby B; Richards HL; Woo P; Hindle E; Main CJ; Griffiths CE
    J Am Acad Dermatol; 2001 Jul; 45(1):72-6. PubMed ID: 11423838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.
    Herédi E; Rencz F; Balogh O; Gulácsi L; Herszényi K; Holló P; Jókai H; Kárpáti S; Péntek M; Remenyik É; Szegedi A; Brodszky V
    Eur J Health Econ; 2014 May; 15 Suppl 1():S111-9. PubMed ID: 24832842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on Psoriasis.
    Maul JT; Maul LV; Didaskalu JA; Valenzuela F; Romiti R; Peterson H; Korouri E; Novoa F; Oon HH; Zheng M; Wu JJ; Thyssen JP; Egeberg A; Armstrong AW; Nielsen ML
    Acta Derm Venereol; 2024 Mar; 104():adv20329. PubMed ID: 38470165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL).
    Lacour JP; Bewley A; Hammond E; Hansen JB; Horne L; Paul C; Reich K; Seneschal J; De Simone C; Sohrt A; Augustin M; Pellacani G
    Dermatol Ther (Heidelb); 2020 Oct; 10(5):1099-1109. PubMed ID: 32761560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.